This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ScanSource (SCSC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
SCSCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Central Pacific Financial (CPF) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CPFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Do Options Traders Know Something About AdaptHealth Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to AHCO stock based on the movements in the options market lately.
AHCONegative Net Change
medical medical-devices
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?
by Moumi Mondal
CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.
UNHPositive Net Change CIPositive Net Change CVSPositive Net Change
medical medical-devices
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
by Zacks Equity Research
LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.
BSXPositive Net Change LHPositive Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
by Zacks Equity Research
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
CAHPositive Net Change MCKNegative Net Change XRAYPositive Net Change COOPositive Net Change
medical medical-devices
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
by Urmimala Biswas
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
AZNPositive Net Change NVDAPositive Net Change BFLYNegative Net Change TEMNegative Net Change
artificial-intelligence earnings-outlook earnings-report earnings-surprise healthcare medical medical-devices smart-health
Natera Shares Rise on the Launch of AI Platform for Precision Oncology
by Zacks Equity Research
NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change NTRAPositive Net Change
medical medical-devices
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AVAHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Backblaze, Inc. (BLZE) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BLZENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
SiteOne Landscape (SITE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SITEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve
by Zacks Equity Research
enVVeno Medical shares plunge after the FDA rejects its VenoValve PMA, citing insufficient trial data and safety concerns tied to the surgical procedure.
LMATPositive Net Change EHCPositive Net Change NVSTNegative Net Change NVNONegative Net Change
medical medical-devices
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
by Moumi Mondal
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
BSXPositive Net Change HOLXNegative Net Change
medical medical-devices
NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer
by Zacks Equity Research
NovoCure submits a PMA to the FDA for TTFields therapy in pancreatic cancer, aiming to expand its oncology reach.
LMATPositive Net Change NVCRNegative Net Change EHCPositive Net Change NVSTNegative Net Change
medical medical-devices
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
by Zacks Equity Research
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change BWAYNo Net Change
medical medical-devices
After Golden Cross, Alector (ALEC)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ALECNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Helios Technologies (HLIO) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HLIONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Stryker's Robotics and Global Gains Offset by Macro Concerns
by Zacks Equity Research
SYK posted strong Q2 growth driven by Mako robotics and global demand, but inflation, FX and competitive pressures temper near-term upside.
JNJNegative Net Change MDTPositive Net Change SYKPositive Net Change ZBHNegative Net Change
medical medical-devices
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
by Moumi Mondal
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
KRPositive Net Change CVSPositive Net Change ELVPositive Net Change
medical medical-devices
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
by Nalak Das
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
BSXPositive Net Change JNJNegative Net Change GEHCNegative Net Change TEMNegative Net Change
medical-devices
Vaso Stock Down Following Q2 Earnings as Revenue and Margins Fall
by Zacks Equity Research
VASO reports a second-quarter 2025 loss as lower imaging deliveries and rising costs pressured revenue and profit margins.
VASONegative Net Change
earnings medical medical-devices
BIAF Stock Down Following Q2 Earnings Despite CyPath Lung Growth
by Zacks Equity Research
bioAffinity shifts its focus on CyPath Lung as the second-quarter 2025 loss widens, with rising adoption and new market expansion underway.
BIAFPositive Net Change
earnings medical medical-devices
Retractable Technologies Stock Gains Following Q2 Earnings Growth
by Zacks Equity Research
RVP reports stronger second-quarter 2025 sales and narrows losses as domestic output offsets tariff headwinds.
RVPNegative Net Change
earnings medical medical-devices
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
by Zacks Equity Research
MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change MBOTPositive Net Change
medical medical-devices
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
by Zacks Equity Research
ANGO benefits from NanoKnife, clinical milestones, and a balanced portfolio despite tariff headwinds.
BSXPositive Net Change ANGOPositive Net Change WSTNegative Net Change MEDPNegative Net Change
medical medical-devices